Nuclear medicine

News • After an initial negative scan

Treatment change for prostate cancer: study reveals benefit of second PSMA PET

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of prostate cancer patients whose first scan was negative, according to new research.

News • Focus on FAP

New radiopharmaceutical therapy shows broad effectiveness across multiple cancers

Radiopharmaceutical therapy has already transformed care for neuroendocrine tumors and prostate cancer, but other tumor types still lack targeted treatment options. A new approach could change this.

News • Novel radiopharmaceutical therapy

Promising treatment option for aggressive neuroendocrine tumors

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options.

News • Nuclear imaging in urology

Prostate cancer: PSMA PET/CT could cut need for biopsies

A PSMA PET/CT imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research finds.

News • Molecular imaging

Rheumatoid arthritis: PET/CT predicts treatment response

A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four weeks, and potentially even at the start of treatment, according to new research.

News • Two tracers, one target

Dual PET approach for personalized head and neck cancer treatment

Beyond "one-size-fits-all": A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research.

News • AI-powered systems and European market growth

United Imaging Showcases Advanced Molecular Imaging Innovations at EANM 2025

At the 38th European Association of Nuclear Medicine (EANM) Congress, held from October 4–8 in Barcelona, United Imaging, a global manufacturer of cutting-edge medical imaging technology, showcases its most advanced AI-powered molecular imaging innovations, the uMI Panvivo family and the uMI Panorama family, and highlights the company’s strong growth and confidence in the European market.

News • Nuclear medicine

PET imaging reveals which patients will (or will not) recover after heart attack

A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor functional recovery after a heart attack, according to new research.

News • New imaging solution

PSMA PET to detect prostate cancer recurrence

A novel imaging solution, called PSMA PET scanning, can more effectively detect the recurrence of prostate cancer compared to standard methods, and is associated with improved survival outcomes.

News • Nuclear imaging

Prostate cancer: High-speed whole-body SPECT tracks tumor evolution

A new type of SPECT imaging provides strong prognostic information to guide prostate cancer treatments according to tumor evolution, significantly impacting patients' overall survival.

News • Weight loss and diabetes medication

GLP-1 agonists may interfere with cancer imaging, new study finds

GLP-1 receptor agonists are widely prescribed for individuals with diabetes and weight loss. However, these medications may adversely affect the interpretation of cancer imaging, new research finds.

News • Focus on adipose tissue metabolism

Endometrial cancer: visceral fat may drive aggressiveness

Using PET/CT imaging, researchers discovered that the biological activity of visceral fat may drive the progression of endometrial cancer, offering a novel angle for diagnosis and treatment.

News • Evaluating tadiotheranostic targets

Endometrial cancer: new markers for PET imaging

Researchers explored two promising new biomarkers as potential radiotheranostic targets for endometrial cancer. This could help identify patients who are likely to respond to targeted therapeutics.

News • Fluorescent 18F-PET imaging

Dual-mode PET tracer lets surgeons see – and hear – prostate cancer

Tracer molecules serve to provide visual guidance in nuclear medicine, but a new molecule could give surgeons additional audio cues to help them locate prostate cancer tumors and metastases.

News • Mycobacteroides abscessus

New PET technique detects hard-to-diagnose lung infections

A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most difficult-to-diagnose conditions in patients with lung diseases.

Heather Jacene, MD

Championing the future of nuclear medicine

Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s Hospital, clinical director of Nuclear Medicine at Dana-Farber Cancer Institute, and associate professor of Radiology at Harvard Medical School in Boston, Massachusetts, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

News • Dual targeting radioligand

“Smart missile” radiopharmaceutical shows promise against multiple cancers

New research makes a strong case for a new dual-targeting radiopharmaceutical, designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy.

Daniela Oprea-Lager

Pushing the boundaries of theranostics

Nuclear medicine specialist Daniela Oprea-Lager has been appointed Professor of Theranostics at Radboudumc / Radboud University. Her research focuses on the combination of diagnostics and treatment using radioactive substances, with particular interest for urological tumors, especially prostate cancer.

News • Hybrid imaging

PET/MR update for added value in theranostics

Bringing diagnostics and therapy closer together - that is the basic concept behind theranostics. Through further development of its PET/MR scanners, Siemens Healthineers aims to advance this approach. Andreas Schneck, Head of the MRI Division at Siemens Healthineers, talks about the new system, which was also presented at the European Congress of Radiology (ECR) in Vienna, and its advantages in…

Article • Insights and perspectives presented at ECR 2025

Nuclear medicine: Innovations, challenges, and new horizons

Nuclear medicine (NM), one of the more mature technologies of diagnostic imaging, has been experiencing a rebirth in innovation and interest. The increasing prevalence of cancer,, an aging global population, and greater longevity, has created a robust demand for nuclear medicine. At ECR in Vienna, presenters explored market perspectives, but also safety and sustainability challenges.

News • Multipurpose radionuclide identification device

Handheld detector is a "Swiss Army knife" for radiation safety

Radiation safety experts developed a multi-purpose detector with a wide range of tools for different uses into a small package. For example, the detector detects all four kinds of ionizing radiation.

News • Nuclear imaging

PET radiotracer reveals inflammation in the brain

Using the COX-2 enzyme, a new PET imaging approach offers a never-before-seen view of inflammation in the brain, opening the door for clinical and research settings for various brain disorders.

News • Nuclear medicine

Lung fibrosis: radiopharmaceutical improves diagnosis and monitoring

Nuclear medicine specialists have successfully used the radiopharmaceutical Ga-68-Trivehexin from Trimt to accurately diagnose patients with pulmonary fibrosis and concurrent lung cancer.

News • Triple-negative breast cancer

Novel radiotracer identifies TNBC biomarker

A new PET tracer has the potential to play a critical role in the diagnosis, treatment, and monitoring of aggressive triple-negative breast cancer (TNBC), improving clinical outcomes for patients.

News • Potential for recovery

PET tracer offers new insights into spinal cord injuries

By detecting nerve connections in the injured spinal cord, a newly developed radiotracer could help diagnose injuries more precisely, monitor recovery, and evaluate therapy effectiveness.

107 show more articles